[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"therapeutic-adherence\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:therapeutic-adherence":75},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100573579",false,"NCT06748118","Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.","Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals: a Stepped-wedge Multicenter Randomized Trial","MAPS","Inclusion Criteria:\n\n* Adult patients (age ≥ 18 years)\n* Affiliated to the French social security system\n* Followed in hospital for a chronic pathology within a formalized care pathway\n* Having signed a consent form to participate in the study.\n\nExclusion Criteria:\n\n* Patients included in the control period.\n* Patients under guardianship.\n* Pregnant or breast-feeding patients.\n* Patients taking part in research on compliance","ALL","18 Years",{"count":19,"type":20},1210,"ESTIMATED","INTERVENTIONAL",[23],"NA","The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare professionals during consultations\u002Finterviews Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action concerning therapeutic adherence. This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake.",[26,27,28,29],"Chronic Disease","Therapeutic Adherence","Training Group, Sensitivity","Delivery Simple, Standardized & Redundant Message to Patient",[31,32],"intervention study","stepped wedge study","RECRUITING","2026-06-29",{"date":36,"type":37},"2026-07-01","ACTUAL",{"date":39,"type":37},"2026-03-18",{"date":41,"type":20},"2028-03",{"name":43,"class":44},"Assistance Publique - Hôpitaux de Paris","OTHER",10,{"id":47,"slug":4,"hasResults":10,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100556508","NCT06526013","Cholesterol Self-testing in Patients Post Acute Coronary Syndrome","C-Check","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value\n* Signed informed consent\n\nExclusion Criteria:\n\n* Persons unable to understand the study\n* Persons unable or unwilling to perform self-measurements\n* Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target\n* Pre-menopausal women without contraception\n* Use of experimental drugs or investigational products within 30 days prior to screening\n* Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter",{"count":53,"type":20},200,[23],"The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a significant need for new strategies to improve LDL-C target achievement and thereby reduce the occurrence of secondary cardiovascular events.\n\nThe aim of the study is to establish a basis for improving prevention by achieving the target LDL level effectively and quickly in patients with high and very high cardiovascular risk profiles.",[57,58,59,27],"Acute Coronary Syndrome","Prevention","LDL Hyperlipoproteinemia",[57,61,62,63,64],"Dyslipidemia","Statin","Lipid lowering therapy","Cardiovascular disease","2024-07-30",{"date":67,"type":37},"2024-08-01",{"date":69,"type":37},"2024-06-01",{"date":71,"type":20},"2025-09-30",{"name":73,"class":44},"University of Leipzig",1,""]